Resistomap: Funding, Investors & Team (Sep 2026)
Resistomap specializes in the combination of microbial antibiotic resistance, molecular genetics, and data science. The company's main objective is to assist researchers, academics, and professionals in quickly and comprehensively identifying and measuring antibiotic resistance genes in environmental samples. This is accomplished by utilizing advanced gene profiling technology. The ultimate aim is to predict and prevent the occurrence of antibiotic-resistant bacteria. Currently, our primary customers are research groups that investigate various environmental samples, including surface water, wastewater, soil, stool, and other tissues. Additionally, Resistomap is in the process of digitalizing antibiotic resistance monitoring in wastewater, which can serve as an early warning system for detecting potential outbreaks of resistant bacteria. We offer a comprehensive range of services, including consultation on sample collection, laboratory assistance for DNA extraction and quantification of antibiotic resistance genes using the SmartChip Real-Time PCR system, thorough data analysis, and the provision of comprehensive reports.
Resistomap has raised $2.2M across 1 funding round on record, the most recent a Seed of $2.2M announced in Nov 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Resistomap Company Profile and Key Stats
Latest funding round on record: Nov 2023.
Resistomap Funding Rounds
Resistomap Founders and Leadership Team
Contact details for the Resistomap team: 1 of 1 has an email address on file.
Start 14-day free trial →Resistomap Funding Compared to Other Biotechnology Startups
Resistomap's latest round of $2.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Resistomap in Biotechnology and Helsinki
Companies Similar to Resistomap
Solar Foods is a food-tech startup that focuses on utilizing a technology that involves using electricity to…
Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to…
Bioretec Ltd. is a Finnish material technology company focused on the development, manufacturing and…
NPHarvest is a company with expertise in organic waste management, wastewater treatment, and nutrient…
They are a pioneering company driven by a passion for innovation and a commitment to solving their partners’…
StemSight is a startup focusing on cell therapy in Tampere, Finland, where they are working on innovative…
Herantis Pharma is a company focused on addressing medical needs that have not been met by current treatments.
Aurealis Therapeutics is a Swiss-Finnish Cell and Gene Therapy Platform Company. Our multi-target cell and…
Eevia Health is a Nordic life science company based in Finland and Norway, with headquarters in Seinäjoki and…
Nexstim is a medical device company focused on image-guided transcranial magnetic stimulation, dedicated to…
Enifer is a company that specializes in using fungal fermentation to create products from byproducts of the…
Resistomap Funding FAQs
What does Resistomap do?
Resistomap specializes in the combination of microbial antibiotic resistance, molecular genetics, and data science. The company's main objective is to assist researchers, academics, and professionals in quickly and comprehensively identifying and measuring antibiotic resistance genes in environmental samples. This is accomplished by utilizing advanced gene profiling technology. The ultimate aim is to predict and prevent the occurrence of antibiotic-resistant bacteria. Currently, our primary customers are research groups that investigate various environmental samples, including surface water, wastewater, soil, stool, and other tissues. Additionally, Resistomap is in the process of digitalizing antibiotic resistance monitoring in wastewater, which can serve as an early warning system for detecting potential outbreaks of resistant bacteria. We offer a comprehensive range of services, including consultation on sample collection, laboratory assistance for DNA extraction and quantification of antibiotic resistance genes using the SmartChip Real-Time PCR system, thorough data analysis, and the provision of comprehensive reports.
How much funding has Resistomap raised?
Resistomap has raised $2.2M across 1 round on record. The most recent is a Seed of $2.2M announced in Nov 2023.
When did Resistomap last raise funding?
Resistomap's most recent funding round on record is a Seed of $2.2M, announced in Nov 2023.
Who is the CEO of Resistomap?
Windi Muziasari is listed as CEO at Resistomap.
Where is Resistomap headquartered?
Resistomap is based in Helsinki, Southern Finland, Finland.
How many employees does Resistomap have?
Resistomap is in the 11-50 employee band.
How does Resistomap's funding compare to other Biotechnology startups?
Resistomap's latest round of $2.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Resistomap Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Resistomap is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.